Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-12 16:34 |
Kamada Announces Changes to its Board of Directors
|
English | 139.6 KB | ||
| 2020-08-12 16:34 |
Kamada Announces Changes to its Board of Directors
|
English | 35.9 KB | ||
| 2020-08-12 16:04 |
Kamada Reports Second Quarter and First Six Months of 2020
|
English | 266.2 KB | ||
| 2020-08-12 16:04 |
Kamada Reports Second Quarter and First Six Months of 2020
|
English | 36.1 KB | ||
| 2020-08-10 16:29 |
Enrollment of First Patient in its Phase 1/2 Clinical Trial of its Plasma-Deriv…
|
English | 115.6 KB | ||
| 2020-08-10 16:29 |
Enrollment of First Patient in its Phase 1/2 Clinical Trial of its Plasma-Deriv…
|
English | 38.0 KB | ||
| 2020-08-05 16:02 |
Kamada to Announce Second Quarter Ended June 30, 2020 Financial Results and Hos…
|
English | 134.1 KB | ||
| 2020-08-05 16:02 |
Kamada to Announce Second Quarter Ended June 30, 2020 Financial Results and Hos…
|
English | 36.1 KB | ||
| 2020-06-17 16:05 |
Kamada Announces Availability of its Plasma-Derived Hyperimmune IgG Therapy for…
|
English | 171.1 KB | ||
| 2020-06-17 16:05 |
Kamada Announces Availability of its Plasma-Derived Hyperimmune IgG Therapy for…
|
English | 38.0 KB | ||
| 2020-05-18 16:04 |
Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corpo…
|
English | 242.8 KB | ||
| 2020-05-18 16:04 |
Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corpo…
|
English | 38.1 KB | ||
| 2020-05-11 16:03 |
Kamada to Announce First Quarter Ended March 31, 2020 Financial Results and Hos…
|
English | 44.1 KB | ||
| 2020-05-11 16:03 |
Kamada to Announce First Quarter Ended March 31, 2020 Financial Results and Hos…
|
English | 37.9 KB | ||
| 2020-04-27 16:02 |
KamadaandKedrionBiopharmaAnnounceGlobalCollaborationfortheDevelopment,Manufactu…
|
English | 209.4 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
